Changeflow GovPing Pharma & Drug Safety USPTO Patent Grant for Caged-Degron Molecular F...
Routine Notice Added Final

USPTO Patent Grant for Caged-Degron Molecular Feedback Circuits

Favicon for changeflow.com ChangeBridge: Patent Grants - Peptides (C07K)
Published March 24th, 2026
Detected March 24th, 2026
Email

Summary

The USPTO has granted patent US12583896B2 to The Regents of the University of California for caged-degron-based molecular feedback circuits. The patent covers methods of modulating signaling pathways in cells using these circuits, with a filing date of January 6, 2020.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12583896B2 for "Caged-degron-based molecular feedback circuits and methods of using the same." The patent, assigned to The Regents of the University of California, details molecular feedback circuits that utilize caged-degrons to control signaling pathways. It includes claims related to nucleic acids encoding these circuits, cells containing them, and methods for modulating cellular signaling pathways through genetic modification.

This patent grant is primarily relevant for entities involved in biotechnology research and development, particularly in the pharmaceutical and medical device sectors. While it does not impose direct compliance obligations, it signifies new intellectual property in the field of synthetic biology and cellular engineering. Companies operating in this space should be aware of this patent to ensure their research and development activities do not infringe upon the granted claims.

Source document (simplified)

← USPTO Patent Grants

Caged-degron-based molecular feedback circuits and methods of using the same

Grant US12583896B2 Kind: B2 Mar 24, 2026

Assignee

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Inventors

David Baker, Scott Boyken, Hana El-Samad, Marc Lajoie, Robert Langan, Andrew Ng

Abstract

Provided are molecular feedback circuits employing caged-degrons. Aspects of such circuits include the use of a caged-degron to modulate the output of a signaling pathway in a feedback-controlled manner. Also provided are nucleic acids encoding molecular circuits and cells containing such nucleic acids. Methods of using caged-degron-based molecular feedback circuits are also provided, including e.g., methods of modulating a signaling pathway of a cell that include genetically modifying the cell with a caged-degron-based molecular feedback circuit.

CPC Classifications

C07K 14/4705 C07K 2319/02 C07K 14/7051 C07K 14/435 A61K 35/17 A61K 48/00 C12N 2740/16043 C12N 15/63 C12N 15/86 C12N 15/79 C12N 15/85 G01N 33/5047

Filing Date

2020-01-06

Application No.

17419236

Claims

11

View original document →

Named provisions

Caged-degron-based molecular feedback circuits and methods of using the same

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12583896B2

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 3254.1 Biotechnology
Activity scope
Drug Labeling Biotechnology Research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.